Ireland
--:--IST
Priya Life Science Compound trial record
Compound · clinical trials

Amoxicillin-clavulanate clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — the 6 trials in our France, Ireland, India, Germany, Spain, Italy, Netherlands, Belgium, Switzerland, Czechia, Portugal, Canada, Japan, Australia, Israel, USA and China registers that name Amoxicillin-clavulanate as an intervention. Synced 9 Nov 2026
6Current trials
4Recruiting now
6Lead sponsors
17Country registers
At a glance

Amoxicillin-clavulanate is named as an intervention in 6 current clinical trials in our France, Ireland, India, Germany, Spain, Italy, Netherlands, Belgium, Switzerland, Czechia, Portugal, Canada, Japan, Australia, Israel, USA and China registers. 4 are recruiting patients now. The most common phase is Phase 3. The sponsor with the most trials is UMC Utrecht (1). The most-studied condition is Respiratory Tract Diseases.

Patient leaflets for Amoxicillin-clavulanate

The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.

  • UK
    United Kingdom: Search MHRA Products
    Patient information leaflets and SmPCs for UK-licensed products.
  • US
    United States: Search DailyMed
    FDA-approved labels, including patient and medication guides.

Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.

Trials by status

  • Recruiting467%
  • Not yet open233%

Trials by phase

  • Phase 3350%
  • Phase 1117%
  • Observational117%
  • Phase 2117%
01

Clinical trials of Amoxicillin-clavulanate

6 trials
StudyPhaseStatusLead sponsorRegisters
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
NCT02735707 · Respiratory Tract Diseases, Influenza (Pandemic), Influenza
Phase 3 Recruiting UMC Utrecht Ireland, India, Germany, France, Spain, Italy, Netherlands, Belgium, Switzerland, Czechia, Portugal, Canada, Japan, Australia, Israel
Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward
NCT06229288 · ClinicalTrials.gov ↗ · Community-acquired Pneumonia
Phase 3 Recruiting Nantes University Hospital France
Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination
NCT06733675 · Healthy Volunteer, Pharmacokinetics, Safety
Phase 1 Recruiting Basilea Pharmaceutica USA
Population Pharmacokinetics of Anti-tuberculosis Drugs in Children With Tuberculosis
NCT03625739 · ClinicalTrials.gov ↗ · Tuberculosis
Observational Recruiting Beijing Children's Hospital China
Efficacy of an Empirical Treatment With Amoxicillin-clavulanate (AC) Compared to the Combination Amoxicillin-clavulanate and Ciprofloxacin (AC+C) in the Outpatient Care of Chemotherapy-induced Fever in Adult Haematology Patients.
NCT07483736 · ClinicalTrials.gov ↗ · C15.378
Phase 3 Not yet open Versailles Hospital France
Patient Choice Between Antibiotics and Appendectomy in Uncomplicated Appendicitis (FRENCH 47 - ALACARTE)
NCT07857252 · ClinicalTrials.gov ↗ · Acute Appendicitis
Phase 2 Not yet open Assistance Publique - Hôpitaux de Paris France

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.

02

Conditions studied with Amoxicillin-clavulanate

12 conditions
Respiratory Tract Diseases1Influenza (Pandemic)1Influenza1Community Acquired Pneumonia1Healthy Volunteer1Pharmacokinetics1Safety1Drug-Drug Interaction (DDI)1Tuberculosis1Community-acquired Pneumonia1C15.3781Acute Appendicitis1
05

Related compounds

06

Questions about Amoxicillin-clavulanate trials

How many clinical trials are testing Amoxicillin-clavulanate?

6 current trials in our France, Ireland, India, Germany, Spain, Italy, Netherlands, Belgium, Switzerland, Czechia, Portugal, Canada, Japan, Australia, Israel, USA and China registers name Amoxicillin-clavulanate as a drug or biological intervention, as of the registry sync on 9 November 2026. Completed and withdrawn studies are not counted.

Are Amoxicillin-clavulanate trials recruiting patients?

Yes. 4 of the 6 trials are recruiting: 2 with sites in France, 1 with sites in Ireland, 1 with sites in India, 1 with sites in Germany, 1 with sites in Spain, 1 with sites in Italy, 1 with sites in Netherlands, 1 with sites in Belgium, 1 with sites in Switzerland, 1 with sites in Czechia, 1 with sites in Portugal, 1 with sites in Canada, 1 with sites in Japan, 1 with sites in Australia, 1 with sites in Israel, 1 with sites in USA and 1 with sites in China. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Who sponsors Amoxicillin-clavulanate clinical trials?

UMC Utrecht (1), Basilea Pharmaceutica (1), Beijing Children's Hospital (1) and Nantes University Hospital (1), among 6 lead sponsors in total. The number in brackets is how many trials each organisation leads.

Are there Amoxicillin-clavulanate clinical trials in Ireland?

Yes. 1 trial in our Ireland register (ClinicalTrials.gov). Some may be the same study registered in both. See the Irish clinical trials register for sites and contacts.

Where does this information come from?

Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Amoxicillin-clavulanate works or whether it is effective, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Amoxicillin-clavulanate works or whether it is effective. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Amoxicillin-clavulanate (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 9 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.